# Zynerba Pharmaceuticals Inc. (ZYNE)

Source: https://www.quantisnow.com/company/ZYNE
Generated: 2026-11-21T12:04:26.375Z

- Ticker: ZYNE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2015
- Website: zynerba.com

## About

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

## Latest ZYNE news and filings

- 2024-02-09 00:22 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Zynerba Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-zynerba-pharmaceuticals-inc-amendment-5243116)
- 2023-10-19 20:48 UTC [SEC Form 15-12G filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-zynerba-pharmaceuticals-inc-5029281)
- 2023-10-12 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-zynerba-pharmaceuticals-inc-5016124)
- 2023-10-11 14:17 UTC [SEC Form 4] [Jones Kenneth T was granted 30,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/jones-kenneth-t-was-granted-30000-shares-closing-all-direct-5014806)
- 2023-10-11 14:12 UTC [SEC Form 4] [Stephenson Pamela closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/stephenson-pamela-closing-all-direct-ownership-in-the-company-sec-5014797)
- 2023-10-11 14:12 UTC [SEC Form 4] [Fickenscher James E was granted 170,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/fickenscher-james-e-was-granted-170000-shares-closing-all-direct-5014796)
- 2023-10-11 14:08 UTC [SEC Form 4] [Sebree Terri B was granted 170,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/sebree-terri-b-was-granted-170000-shares-closing-all-direct-5014790)
- 2023-10-11 14:07 UTC [SEC Form 4] [Federici William J closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/federici-william-j-closing-all-direct-ownership-in-the-company-5014787)
- 2023-10-11 14:05 UTC [SEC Form 4] [Rosenberger Brian was granted 120,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/rosenberger-brian-was-granted-120000-shares-closing-all-direct-ownership-5014779)
- 2023-10-11 14:03 UTC [SEC Form 4] [Cooper Warren D closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/cooper-warren-d-closing-all-direct-ownership-in-the-company-5014774)
- 2023-10-11 14:02 UTC [SEC Form 4] [Parker Albert P was granted 85,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/parker-albert-p-was-granted-85000-shares-closing-all-direct-5014770)
- 2023-10-11 13:58 UTC [SEC Form 4] [Butler John P. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/butler-john-p-closing-all-direct-ownership-in-the-company-5014740)
- 2023-10-11 13:58 UTC [SEC Form 4] [Moch Kenneth I closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/moch-kenneth-i-closing-all-direct-ownership-in-the-company-5014738)
- 2023-10-11 13:52 UTC [SEC Form 4] [Anido Armando was granted 240,000 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/anido-armando-was-granted-240000-shares-closing-all-direct-ownership-5014730)
- 2023-10-11 13:52 UTC [SEC Form 4] [Kisner Daniel L closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/kisner-daniel-l-closing-all-direct-ownership-in-the-company-5014728)
- 2023-10-11 13:27 UTC [SEC Form POS AM filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-zynerba-pharmaceuticals-inc-5014689)
- 2023-10-11 13:27 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014684)
- 2023-10-11 13:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014675)
- 2023-10-11 13:25 UTC [Market Insight] [New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies](https://www.quantisnow.com/insight/new-possibilities-for-cannabinoid-treatments-acquisition-to-transform-neuropsychiatric-disorder-5014673)
- 2023-10-11 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014665)
- 2023-10-11 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014663)
- 2023-10-11 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014661)
- 2023-10-11 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014659)
- 2023-10-11 13:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014655)
- 2023-10-11 13:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014650)
- 2023-10-11 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014649)
- 2023-10-11 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-zynerba-pharmaceuticals-inc-5014647)
- 2023-10-11 12:56 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Zynerba Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-zynerba-pharmaceuticals-inc-amendment-5014510)
- 2023-10-11 12:17 UTC [SEC Form 8-K] [Zynerba Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/zynerba-pharmaceuticals-inc-filed-sec-form-8-k-completion-of-acquisition-5014392)
- 2023-10-11 12:12 UTC [SEC Form 25-NSE filed by Zynerba Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-zynerba-pharmaceuticals-inc-5014374)
- 2023-10-11 12:00 UTC [Mergers & Acquisitions] [HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE](https://www.quantisnow.com/insight/harmony-biosciences-completes-acquisition-of-zynerba-pharmaceuticals-and-expands-pipeline-5014298)
- 2023-10-04 21:29 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Zynerba Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-zynerba-pharmaceuticals-inc-amendment-5005246)
- 2023-10-04 20:05 UTC [Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions](https://www.quantisnow.com/insight/important-information-for-zynerba-pharmaceuticals-stockholders-to-tender-shares-for-5004366)
- 2023-09-29 13:10 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Zynerba Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-zynerba-pharmaceuticals-inc-amendment-4994256)
- 2023-09-29 13:00 UTC [Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023](https://www.quantisnow.com/insight/zynerba-pharmaceuticals-stockholders-reminded-to-tender-shares-before-500-pm-4994194)
- 2023-09-27 12:25 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Zynerba Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-zynerba-pharmaceuticals-inc-amendment-4989700)
- 2023-09-27 12:04 UTC [Market Chatter] [Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/harmony-biosciences-announces-extension-of-tender-offer-to-acquire-zynerba-4989649)
- 2023-09-27 12:00 UTC [HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.](https://www.quantisnow.com/insight/harmony-biosciences-announces-extension-of-tender-offer-to-acquire-zynerba-4989600)
- 2023-09-26 21:30 UTC [Market Insight] [Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023](https://www.quantisnow.com/insight/bearish-sentiment-across-the-cannabis-space---check-full-movers-4988989)
- 2023-09-18 21:30 UTC [Market Insight] [Cannabis Stock Movers For September 18, 2023](https://www.quantisnow.com/insight/cannabis-stock-movers-for-september-18-2023-4976426)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ZYNE
- Earnings history: https://www.quantisnow.com/earnings/ZYNE
- Dividend history: https://www.quantisnow.com/dividends/ZYNE
- Insider transactions: https://www.quantisnow.com/insiders/ZYNE
- Options chain: https://www.quantisnow.com/options/ZYNE
- SEC 8-K filings only: https://www.quantisnow.com/company/ZYNE/8-k
- RSS and alerts for ZYNE: https://www.quantisnow.com/docs/rss-feeds.md
